loder, who hasn't been involved with any cgrp drug studies, cautions that these medicines don't work for everybody. and they may be risky for some people..
please keep our community civil. comments should remain on topic and be respectful.. is the place to come for breaking news, analysis and for stories that are just too interesting – or too entertaining – to pass up..
of all car-t cell trials registered since 2001, more than half are being conducted in china..the financial times and its journalism are subject to a self-regulation regime under the ft editorial code of practice: